Your browser doesn't support javascript.
loading
Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study.
Björnsson, Oddur; Jónsson, Eiríkur; Guðmundsson, Eiríkur Orri; Marteinsson, Valur Þór; Nikulásson, Sigfús Þór; Guðjónsson, Sigurður.
Afiliação
  • Björnsson O; Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
  • Jónsson E; Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
  • Guðmundsson EO; Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
  • Marteinsson VÞ; Department of Surgery, Akureyri Hospital, Akureyri, Iceland.
  • Nikulásson SÞ; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Guðjónsson S; Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
Scand J Urol ; 55(3): 197-202, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33913379
ABSTRACT

OBJECTIVE:

Radical nephroureterectomy is the standard treatment of organ-confined upper tract urothelial carcinoma (UTUC). The objective of this study was to investigate survival and bladder recurrence rate in Icelandic patients with UTUC who underwent radical nephroureterctomy (RNU) or other procedures with curative intent. MATERIAL AND

METHODS:

All patients who were diagnosed with UTUC in Iceland from 2003 to 2016 and treated with curative intent were included in the study. Information on patients was obtained retrospectively from patients' medical records and from the Icelandic Cause of Death Registry.

RESULTS:

Overall 63 patients underwent a procedure for UTUC with curative intent in Iceland during the study period. The median age was 71 years and the majority were male (65%). In 50 patients (79%), the tumor was a primary UTUC. The most common procedure was RNU (78%) and eight patients (13%) underwent a kidney-sparing procedure. No patient died within 90 d of surgery. Twenty-eight patients (44%) had pathological stage T2 or higher, whereas 35 patients (56%) had pathological stage T1 or lower. The median follow-up time was 98.8 months . During the follow-up time 25 patients (40%) were diagnosed with recurrence in the bladder. Five-year cancer-specific survival (CSS) was 67%.

CONCLUSIONS:

This population-based study shows that the oncologic outcome in Icelandic patients with UTUC is similar to what has been reported in other countries. Bladder recurrence rate is high and can hopefully be reduced by improvements in surgical and intravesical instillation treatment. Possibly more kidney-sparing surgeries could have been done during the study period; however, careful selection for those procedures is mandatory.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Scand J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Islândia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Scand J Urol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Islândia